These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8459913)

  • 1. A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system.
    Valk J; Algra PR; Hazenberg CJ; Slooff WB; Svaland MG
    Neuroradiology; 1993; 35(3):173-7. PubMed ID: 8459913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
    Akeson P; Jonsson E; Haugen I; Holtås S
    Neuroradiology; 1995 Apr; 37(3):229-33. PubMed ID: 7603600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
    Chanalet S; Masson B; Boyer L; Laffont J; Bruneton JN
    J Radiol; 1995 Jul; 76(7):417-21. PubMed ID: 7473375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
    Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
    AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
    Lundby B; Gordon P; Hugo F
    Eur J Radiol; 1996 Nov; 23(3):190-6. PubMed ID: 9003923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.
    Demaerel P; Marchal G; Wilms G; Van Calenbergh F; De Greef D; Børseth A; Baert AL
    Neuroradiology; 1994 Jul; 36(5):355-9. PubMed ID: 7936174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs.
    Skalpe IO; Tang GJ
    Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
    Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
    Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
    Aslanian V; Lemaignen H; Bunouf P; Schiratti M; Lambrechts M; Lundby B; Borseth A; Svaland M
    J Radiol; 1995 Jul; 76(7):431-4. PubMed ID: 7473377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study.
    Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB
    Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
    Aslanian V; Lemaignen H; Bunouf P; Svaland MG; Borseth A; Lundby B
    Neuroradiology; 1996 Aug; 38(6):537-41. PubMed ID: 8880714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.
    Balériaux D; Matos C; De Greef D
    Neuroradiology; 1993; 35(7):490-4. PubMed ID: 8232870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.